Neurology

Your Article Summary

See Latest Articles

Antiplatelet therapy for prevention of recurrent stroke
Current Treatment Options in Neurology, 10/30/09

Badruddin A et al. – When choosing an antiplatelet agent for this purpose, clinicians should take into account cost, side effect profile, medical comorbidity, and patient preference. To prevent recurrent stroke, aspirin alone (50–325 mg/d), a combination of aspirin (25 mg) plus extended–release dipyridamole (200 mg), given twice daily, or clopidogrel (75 mg/d) may be used as initial treatment. Prasugrel, a new thienopyridine derivative, more quickly and consistently inhibits platelets than clopidogrel. In stroke patients, prasugrel may be associated with a higher risk of brain hemorrhage, so it may not be indicated when there is a history of cerebrovascular disease.

Today in Stroke/Vascular...keeping you current

Receive free subspecialty "5-minute updates" via email

Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy , 10/20/09

Statin use and neurologic morbidity after coronary artery bypass grafting. A cohort study
Neurology, 11/16/09

Outcome of intracerebral haemorrhage patients pre-treated with statins
European Journal of Neurology, 11/17/09

See All of Stroke/Vascular